Liraglutide shows efficacy in boosting liver enzymes in diabetes

12/2/2012 | Modern Medicine

Data from six Liraglutide Effect and Action in Diabetes program trials showed liraglutide and other GLP-1 analogues were safe and effective in improving liver enzymes in overweight type 2 diabetes patients. Liraglutide also fared better than placebo in reducing alanine transaminase levels in patients, researchers wrote in the journal Alimentary Pharmacology and Therapeutics.

View Full Article in:

Modern Medicine

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT